Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:MYOS MYOS RENS Technology (MYOS) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About MYOS RENS Technology Stock (NASDAQ:MYOS) 30 days 90 days 365 days Advanced Chart Ad DTII've got news for you… Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the weekwatch this FREE briefing with me and expert trader Graham Lindman Get MYOS RENS Technology alerts:Sign Up Key Stats Today's Range N/A50-Day Range$1.01▼$11.4052-Week Range N/AVolumeN/AAverage Volume1.68 million shsMarket Capitalization$16.70 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewMedAvail Holdings, Inc. is a technology-enabled pharmacy company. It provides turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. The firm helps patients to optimize drug adherence, resulting in better health outcomes. The company is headquartered in Mississauga, Canada.Read More… I've got news for you… (Ad)Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the weekwatch this FREE briefing with me and expert trader Graham Lindman Receive MYOS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MYOS RENS Technology and its competitors with MarketBeat's FREE daily newsletter. Email Address MYOS Stock News HeadlinesRen Systems Raises $3.5M, Partners With ZoomInfo to Bring AI-powered Relationship Intelligence to Dealmakers at 35,000 BusinessesSeptember 12, 2024 | venturebeat.comNew Study Evaluates Use of the Nerivio® REN Wearable for Treatment of Migraine in Children Under the Age of 12July 25, 2024 | tmcnet.comDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.November 27, 2024 | DTI (Ad)Ren Zhengfei says US government 'underestimates' HuaweiDecember 23, 2023 | bbc.comBio-active Peptides Market Size 2023-2031 Industrial Trends by Absolute Reports | with [93 Pages]May 11, 2023 | marketwatch.comLatest "Bio-active Peptides Market" Size Forecast 2023-2031: New Challenges, Drivers, and RestraintsMay 8, 2023 | marketwatch.comBio-active Peptides Market Size Dynamics 2023-2029April 13, 2023 | marketwatch.comGlobal Bio-active Peptides Market: Future Extrapolations and Emerging Updates for 2023-2027March 21, 2023 | marketwatch.comSee More Headlines MYOS Stock Analysis - Frequently Asked Questions How were MYOS RENS Technology's earnings last quarter? MYOS RENS Technology Inc. (NASDAQ:MYOS) issued its quarterly earnings results on Tuesday, August, 6th. The company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.12) by $0.01. The business earned $0.15 million during the quarter, compared to the consensus estimate of $0.14 million. MYOS RENS Technology had a negative trailing twelve-month return on equity of 166.68% and a negative net margin of 277.82%. What other stocks do shareholders of MYOS RENS Technology own? Based on aggregate information from My MarketBeat watchlists, some other companies that MYOS RENS Technology investors own include Chesapeake Energy (CHKAQ), Catalyst Pharmaceuticals (CPRX), Ampio Pharmaceuticals (AMPE), Biocept (BIOC), T2 Biosystems (TTOO), AbbVie (ABBV) and Global Blood Therapeutics (GBT). Company Calendar Last Earnings8/06/2019Today11/27/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolNASDAQ:MYOS CUSIPN/A CIK1402479 Webwww.myosrens.com Phone(905) 812-0023FaxN/AEmployees15Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,260,000.00 Net Margins-277.82% Pretax MarginN/A Return on Equity-166.68% Return on Assets-104.95% Debt Debt-to-Equity Ratio0.11 Current Ratio3.78 Quick Ratio1.94 Sales & Book Value Annual Sales$1.03 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$0.13 per share Price / BookN/AMiscellaneous Outstanding Shares12,192,000Free FloatN/AMarket Cap$16.70 million OptionableNot Optionable Beta1.08 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report This page (NASDAQ:MYOS) was last updated on 11/27/2024 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MYOS RENS Technology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MYOS RENS Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
